Michael Nagel - Oct 5, 2023 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBP)

Role
Director
Signature
/s/ Michael Nagel
Stock symbol
KRBP
Transactions as of
Oct 5, 2023
Transactions value $
$0
Form type
4
Date filed
10/6/2023, 04:07 PM
Previous filing
Jul 5, 2022
Next filing
Mar 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRBP Restricted Stock Units Award $0 +18K $0.00 18K Oct 5, 2023 Common Stock 18K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU.